rs2254358

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_005529.7(HSPG2):​c.474G>T​(p.Gly158Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.629 in 1,613,166 control chromosomes in the GnomAD database, including 328,190 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 23646 hom., cov: 31)
Exomes 𝑓: 0.64 ( 304544 hom. )

Consequence

HSPG2
NM_005529.7 synonymous

Scores

1
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.592

Publications

25 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
  • Schwartz-Jampel syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Silverman-Handmaker type dyssegmental dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Schwartz-Jampel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.022).
BP6
Variant 1-21890081-C-A is Benign according to our data. Variant chr1-21890081-C-A is described in ClinVar as Benign. ClinVar VariationId is 295910.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.592 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.659 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005529.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
NM_005529.7
MANE Select
c.474G>Tp.Gly158Gly
synonymous
Exon 6 of 97NP_005520.4
HSPG2
NM_001291860.2
c.474G>Tp.Gly158Gly
synonymous
Exon 6 of 97NP_001278789.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
ENST00000374695.8
TSL:1 MANE Select
c.474G>Tp.Gly158Gly
synonymous
Exon 6 of 97ENSP00000363827.3
HSPG2
ENST00000374673.4
TSL:3
c.228G>Tp.Gly76Gly
synonymous
Exon 3 of 7ENSP00000497688.1
HSPG2
ENST00000412328.5
TSL:2
n.242G>T
non_coding_transcript_exon
Exon 3 of 6

Frequencies

GnomAD3 genomes
AF:
0.532
AC:
80751
AN:
151752
Hom.:
23644
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.295
Gnomad AMI
AF:
0.515
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.758
Gnomad EAS
AF:
0.369
Gnomad SAS
AF:
0.601
Gnomad FIN
AF:
0.644
Gnomad MID
AF:
0.712
Gnomad NFE
AF:
0.664
Gnomad OTH
AF:
0.570
GnomAD2 exomes
AF:
0.577
AC:
145150
AN:
251382
AF XY:
0.594
show subpopulations
Gnomad AFR exome
AF:
0.290
Gnomad AMR exome
AF:
0.416
Gnomad ASJ exome
AF:
0.747
Gnomad EAS exome
AF:
0.374
Gnomad FIN exome
AF:
0.642
Gnomad NFE exome
AF:
0.666
Gnomad OTH exome
AF:
0.603
GnomAD4 exome
AF:
0.640
AC:
934702
AN:
1461298
Hom.:
304544
Cov.:
50
AF XY:
0.641
AC XY:
466034
AN XY:
727006
show subpopulations
African (AFR)
AF:
0.286
AC:
9572
AN:
33470
American (AMR)
AF:
0.425
AC:
19008
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.750
AC:
19612
AN:
26134
East Asian (EAS)
AF:
0.406
AC:
16100
AN:
39694
South Asian (SAS)
AF:
0.594
AC:
51197
AN:
86248
European-Finnish (FIN)
AF:
0.635
AC:
33929
AN:
53408
Middle Eastern (MID)
AF:
0.674
AC:
3882
AN:
5762
European-Non Finnish (NFE)
AF:
0.669
AC:
743889
AN:
1111480
Other (OTH)
AF:
0.621
AC:
37513
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
18786
37573
56359
75146
93932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19036
38072
57108
76144
95180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.532
AC:
80763
AN:
151868
Hom.:
23646
Cov.:
31
AF XY:
0.530
AC XY:
39320
AN XY:
74198
show subpopulations
African (AFR)
AF:
0.294
AC:
12182
AN:
41400
American (AMR)
AF:
0.483
AC:
7384
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.758
AC:
2626
AN:
3466
East Asian (EAS)
AF:
0.369
AC:
1900
AN:
5146
South Asian (SAS)
AF:
0.601
AC:
2892
AN:
4810
European-Finnish (FIN)
AF:
0.644
AC:
6784
AN:
10540
Middle Eastern (MID)
AF:
0.718
AC:
211
AN:
294
European-Non Finnish (NFE)
AF:
0.664
AC:
45110
AN:
67924
Other (OTH)
AF:
0.572
AC:
1205
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1722
3445
5167
6890
8612
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.621
Hom.:
123616
Bravo
AF:
0.512
Asia WGS
AF:
0.496
AC:
1724
AN:
3478
EpiCase
AF:
0.675
EpiControl
AF:
0.689

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
Lethal Kniest-like syndrome (2)
-
-
2
Schwartz-Jampel syndrome (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
1.7
DANN
Uncertain
0.98
PhyloP100
-0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2254358; hg19: chr1-22216574; COSMIC: COSV65930404; COSMIC: COSV65930404; API